Fusion of metabolomics and proteomics data for biomarkers discovery: Case study on the experimental autoimmune encephalomyelitis

BMC Bioinformatics

Volumn 12, Issue , 2011, Pages

  Blanchet, Lionel ^a   Smolinska, Agnieszka ^a   Attali, Amos ^b   Stoop, Marcel P ^c   Ampt, Kirsten A M ^a   van Aken, Hans ^b   Suidgeest, Ernst ^b   Tuinstra, Tinka ^b   Wijmenga, Sybren S ^a   Luider, Theo ^c   Buydens, Lutgarde M C ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b Chemical Design and Synthesis Unit   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL INTERPRETATION; CENTRAL NERVOUS SYSTEMS; CEREBRO SPINAL FLUIDS; COMBINED INFORMATIONS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FUSION ARCHITECTURE; HIGH DIMENSIONALITY; MULTIPLE SCLEROSIS;

CEREBROSPINAL FLUID; MOLECULAR BIOLOGY; NEUROLOGY; PATHOLOGY; RATS;

PROTEINS;

RATTUS;

BIOLOGICAL MARKER;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ARTICLE; CEREBROSPINAL FLUID; CHEMISTRY; LEWIS RAT; MALE; METABOLISM; METABOLOMICS; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE; PROTEOMICS; RAT;

ANIMALS; BIOLOGICAL MARKERS; CEREBROSPINAL FLUID; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MALE; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEOMICS; RATS; RATS, INBRED LEW;

EID: 79959371685     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-12-254     Document Type: Article

References (54)

1. Silberring J, Ciborowski P. Biomarkers discovery and clinical proteomics. TrAC Trend anal Chem 2010, 29(2):128-140.
2. Chambers G, Lawrie L, Cash P, Murray GI. Proteomics: a new approach to the study of disease. J Pathol 2000, 192(3):280-288. 10.1002/1096-9896(200011)192:3<280::AID-PATH748>3.0.CO;2-L, 11054709.
3. Gowda GAN, Zhang S, Gu H, Asiago V, Shanaiah N, Raftery D. Metabolomics-based methods for early disease diagnostics. Expert Rev Mol Diagn 2008, 8(5):617-633. 10.1586/14737159.8.5.617, 18785810.
4. van der Greef J, Stroobant P, van der Heijden R. The role of analytical sciences in medical systems biology. Curr Opin Chem Biol 2004, 8(5):559-565. 10.1016/j.cbpa.2004.08.013, 15450501.
5. Ibrahim SM, Gold R. Genomics, proteomics, metabolomics: what is in a word for multiple sclerosis?. Curr Opin Neurol 2005, 18(3):231-235. 10.1097/01.wco.0000169738.06664.3b, 15891405.
6. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 2000, 28(1):27-30. 10.1093/nar/28.1.27, 102409, 10592173.
7. Pearson H. Meet the human metabolome. Nature 2007, 446(7131):8-8. 10.1038/446008a, 17330009.
8. Ghoumari AM, Ibanez C, El-Etr M, Leclerc P, Eychenne B, O'Malley BW, Baulieu EE, Schumacher M. Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J Neurochem 2003, 86(4):848-859. 10.1046/j.1471-4159.2003.01881.x, 12887683.
9. Kitano H. Systems Biology: a brief overview. Science 2002, 295(5560):1662-1664. 10.1126/science.1069492, 11872829.
10. Dumas M-E, Canlet C, Debrauwer L, Martin P, Paris A. Selection of biomarkers by a multivariate statistical processing of composite metabonomic data sets using multiple factor analysis. J Prot Res 2005, 4(5):1485-1492.
11. Thomas CE, Ganji G. Integration of genomic and metabonomic data in systems biology - are we 'there' yet?. Curr Opin Drug Disc Dev 2006, 9(1):92-100.
12. Kaddurah-Daouk R, Krishnan RR. Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology 2009, 34(1):173-186. 10.1038/npp.2008.174, 18843269.
13. Compston A, Coles A. Multiple Sclerosis. Lancet 2008, 372(9648):1502-1517. 10.1016/S0140-6736(08)61620-7, 18970977.
14. Baxter AG. The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol 2007, 7(11):904-912. 10.1038/nri2190, 17917672.
15. Lipton MM, Freund J. Encephalomyelitis in the rat following intacutaneous injection of the central nervous system tissue with adjuvant. Proc Soc Exp Biol NY 1952, 81(2):260-261.
16. Roussel S, Bellon-Maurel V, Roger J-M, Grenier P. Fusion of aroma, FT-IR and UV sensor data based on the Bayesian inference. Application to the discrimination of white grapes varieties. Chemom Intell Lab Syst 2003, 65(2):209-219.
17. Norgaard L, Bro R, Westad F, Engelsen SB. A modification of canonical variates analysis to handle highly collinear multivariate data. J Chemom 2006, 20(8):425-435.
18. Hastie T, Tibshirani R, Friedman J. The elements of statistical learning: data mining, inference and prediction. 2001, New York: Springer.
19. Hendriks JJA, Alblas J, Van Der Pol SMA, Van Tol EAF, Dijkstra CD, De Vries HE. Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis. J Exp Med 2004, 200(12):1667-1672. 10.1084/jem.20040819, 2212002, 15611292.
20. Olsen JV, de Godoy LMF, Li G, Macek B, Mortensen P, Pesch R, Makarov A, Lange O, Horning S, Mann M. Parts per million mass accuracy on an orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics 2005, 4(12):2010-2021. 10.1074/mcp.T500030-MCP200, 16249172.
21. Eilers PHC. Parametric time warping. Anal Chem 2004, 76(2):404-411. 10.1021/ac034800e, 14719890.
22. Bloemberg TG, Gerretzen J, Wouters HJP, Gloerich J, van Dael M, Wessels HJCT, van den Heuvel LP, Eilers PHC, Buydens LMC, Wehrens R. Improved parametric time warping for proteomics. Chemom Intell Lab Syst
23. De Meyer T, Sinnaeve D, Van Gasse B, Tsiporkova E, Rietzschel ER, De Buyzere ML, Gillebert TC, Bekaert S, Martins JC, Van Criekinge W. NMR-based characterization of metabolic alterations in hypertension using an adaptive, intelligent binning algorithm. Anal Chem 2008, 80(10):3783-3790. 10.1021/ac7025964, 18419139.
24. Krzanowski WJ. Principles of Multivariate Analysis. 2000, Oxford: Oxford university press.
25. Hubert M, Engelen S. Robust PCA and classification in biosciences. Bioinformatics 2004, 20(11):1728-1736. 10.1093/bioinformatics/bth158, 14988110.
26. Hubert M, Rousseeuw P, van der Branden K. ROBPCA: A new approach to robust principal component analysis. Technometrics 2005, 47(1):64-79.
27. Vandeginste BGM, Buydens LMC, de Jong S, Lewi PJ, Smeyers-Verbeke J, Massart DL. Handbook of Chemometrics and Qualimetrics: Handbook of Chemometrics and Qualimetrics: Part B. 1998, 20. Amsterdam: Elsevier.
28. Brown SD, Tauler R, Walczak B, . eds Comprehensive Chemometrics. 2009, Amsterdam: Elsevier, eds.
29. Norgaard L, Soletormos G, Harrit N, Morten A, Olsen O, Nielsen D, Kampmann K, Bro R. Fluorescence spectroscopy and chemometrics for classification of breast cancer samples-a feasibility study using extended canonical variates analysis. J Chemom 2007, 2007(10):451-458.
30. Keun HC, Ebbels TMD, Antti H, Bollard ME, Beckonert O, Holmes E, Lindon JC, Nicholson JK. Improved analysis of multivariate data by variable stability scaling: application to NMR-based metabolic profiling. Anal Chim Acta 2003, 490(1-2):265-276.
31. Andresson CA, Bro R. The N-way toolbox for MATLAB. Chemom Intell Lab Syst 2000, 52(1):1-4.
32. Missing toolbox. , http://www.models.life.ku.dk/source/
33. Andersson CA, Bro R. Improving the speed of multi-way algorithms: Part I. Tucker 3. Chemom Intell Lab Syst 1998, 42(1-2):93-103.
34. Walczak B. Dealing with missing data. Part I. Chemom Intell Lab Syst 2001, 58(1):15-27.
35. Kennard RW, Stone LA. Computer aided design of experiments. Technometrics 1969, 11(1):137-148.
36. Opgen-Rhein R, Strimmer K. From correlation to causation networks: a simple approximate learning algorithm and its application to high-dimensional plant gene expression. BMC Syst Biol 2007, 1:37. 10.1186/1752-0509-1-37, 1995222, 17683609.
37. Graphviz - Graph Visualization Software. , http://www.graphviz.org/
38. Draisma HHM, Reijmers TH, van der Kloet F, Bobeldik-Pastorova I, Spies-Faber E, Vogels JTWE, Meulman J, Boomsma DI, van der Greef J, Hankemeier T. Equating, or correction for between-block effects with application to body fluid LC-MS and NMR metabolomics data sets. Anal Chem 2010, 82(3):1039-1046. 10.1021/ac902346a, 20052990.
39. Lavine BK, Rayens WS. Statistical Discriminant Analysis. Comprehensive Chemometrics 2009, 3:517-540. Amsterdam: Elsevier, Brown SD, Tauler R, Walczak B.
40. Rithidech KN, Honikel L, Milazzo M, Madian D, Troxell R, Krupp LB. Protein expression profiles in pediatric multiple sclerosis: potential biomarkers. Mult Scler 2009, 15(4):455-464.
41. Liu T, Donahue K, Hu J, Kurnellas MP, Grant JE, Li H, Elkabes S. Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord. J Prot Res 2007, 6(7):2565-2575.
42. Hammack BN, Fung KYC, Hunsucker SW, Duncan MW, Burgoon MP, Owens GP, Gilden DH. Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult Scler 2004, 10(3):245-260. 10.1191/1352458504ms1023oa, 15222687.
43. Prat A, Biernacki K, Saroli T, Orav JE, Guttman CRG, Weiner HL, Kroury SJ, Antel JP. Kinin B1 receptor expression on multiple sclerosis mononuclear cells: Correlation with magnetic resonance imaging T2-weighted lesion volume and clinical disability. Arch Neurol 2005, 62(5):795-800. 10.1001/archneur.62.5.795, 15883268.
44. Rabchevsky AG, Degos J-D, Dreyfus PA. Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood-brain barrier without inducing reactive gliosis. Brain Res 1999, 832(1-2):84-96. 10.1016/S0006-8993(99)01479-1, 10375654.
45. Dumont D, Noben J-P, Raus J, Stinissen P, Robben J. Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics 2004, 4(7):2117-2124. 10.1002/pmic.200300715, 15221773.
46. Jongen PJH, Doesburg WH, Ibrahim-Stappers JLM, Lemmens WAJG, Hommes OR, Lamers KJB. Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system. Acta Neurol Scand 2000, 101(2):116-121. 10.1034/j.1600-0404.2000.101002116.x, 10685859.
47. Gay FW. Early cellular events in multiple sclerosis Intimations of an extrinsic myelinolytic antigen. Clin Neurol Neurosurg 2006, 108(3):234-240. 10.1016/j.clineuro.2005.11.005, 16364541.
48. Stoop MP, Dekker LJ, Titulaer MK, Burgers PC, Sillevis Smitt PAE, Luider T, Hintzen RQ. Multiple sclerosis related proteins identified in CSF by advanced mass spectrometry. Proteomics 2008, 8(8):1576-1585. 10.1002/pmic.200700446, 18351689.
49. Ingram G, Hakobyan S, Robertson NP, Morgan BP. Elevated plasma C4a levels in multiple sclerosis correlate with disease activity. J Neuroimmunol 2010, 223(1-2):124-127. 10.1016/j.jneuroim.2010.03.014, 20409594.
50. Barnum SR, Szalai AJ. Complement and demyelinating disease: No MAC needed?. Brain Res Rev 2006, 52(1):58-68. 10.1016/j.brainresrev.2005.12.002, 16443278.
51. Galicia G, Maes W, Verbinnen B, Kasran A, Bullens D, Arredouani M, Ceuppens JL. Haptoglobin deficiency facilitates the development of autoimmune inflammation. Eur J Immunol 2009, 39(12):3404-3412. 10.1002/eji.200939291, 19795414.
52. Hunter MIS, Nlemadim BC, Davidson DLW. Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients. Neurochem Res 1985, 10(12):1645-1652. 10.1007/BF00988606, 4088434.
53. Sinclair AJ, Viant MR, Ball AK, Burdon MA, Walker EA, Stewart PW, Rauz S, Young SP. NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases - a diagnostic tool?. NMR Biomed 2010, 23(2):123-132.
54. Li P, Yin Y-L, Li D, Kim SW, Wu G. Amino acids and immune function. Brit J Nutr 2007, 98(2):237-252. 10.1017/S000711450769936X, 17403271.